Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Yingni Sun"'
Publikováno v:
Frontiers in Aging Neuroscience, Vol 16 (2024)
Alzheimer’s disease (AD) is the most common fatal neurodegenerative disease among the elderly worldwide, characterized by memory and cognitive impairment. The identification of biomarkers for AD is crucial and urgent to facilitate the diagnosis and
Externí odkaz:
https://doaj.org/article/f7a5aefa18354c889bb2fc4727e8b394
Autor:
Yingjin CHAI, Xiaoxiao GU, Yingni SUN, Jie LI, Xiaolan WANG, Xin HUANG, Xia ZHOU, Mengli HAN, Fagang ZHONG, Xingxing ZHANG, Tongzhong WU
Publikováno v:
Kafkas Universitesi Veteriner Fakültesi Dergisi, Vol 30, Iss 1, Pp 63-71 (2023)
Escherichia coli is an important component of the normal bacterial community in humans and animals. However, in recent years, the pathogenicity of some virulent strains to the outside of the intestine has been confirmed in clinical medicine. The purp
Externí odkaz:
https://doaj.org/article/ae2790cd504b4aeba0a8c25fd5609f1e
Publikováno v:
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 35, Iss 1, Pp 1027-1044 (2020)
As one of the world’s five terminally ills, tumours can cause important genetic dysfunction. However, some current medicines for tumours usually have strong toxic side effects and are prone to drug resistance. Studies have found that farnesyltransf
Externí odkaz:
https://doaj.org/article/2b2414936e2c4195acb8ecf0839f392e
Publikováno v:
Frontiers in Aging Neuroscience, Vol 13 (2021)
Alzheimer’s disease (AD) is the most common fatal neurodegenerative disease of the elderly worldwide. The identification of AD biomarkers will allow for earlier diagnosis and thus earlier intervention. The aim of this study was to find such biomark
Externí odkaz:
https://doaj.org/article/c0138703b66547b3a7ae73d83698c0de
Publikováno v:
Frontiers in Aging Neuroscience, Vol 11 (2019)
The identification of biomarkers of Alzheimer’s disease (AD) is an important and urgent area of study, not only to aid in the early diagnosis of AD, but also to evaluate potentially new anti-AD drugs. The aim of this study was to explore cofilin 2
Externí odkaz:
https://doaj.org/article/5032108a6cd241b3b02792ae8ef0532e
Publikováno v:
Acta Biochimica et Biophysica Sinica; Feb2024, Vol. 56 Issue 2, p162-173, 12p
Autor:
Yingjin CHAI, Xiaoxiao GU, Yingni SUN, Jie LI, Xiaolan WANG, Xin HUANG, Xia ZHOU, Mengli HAN, Fagang ZHONG, Xingxing ZHANG, Tongzhong WU
Publikováno v:
Kafkas Universitesi Veteriner Fakultesi Dergisi; Jan/Feb2024, Vol. 30 Issue 1, p63-71, 9p
Publikováno v:
CNS Neuroscience & Therapeutics. 28:1108-1123
dl-PHPB (potassium 2-(1-hydroxypentyl)-benzoate) has been shown to have neuroprotective effects against acute cerebral ischemia, vascular dementia, and Alzheimer's disease. The aim of this study was to investigate the effects of dl-PHPB on memory def
Publikováno v:
Biomedicinepharmacotherapy = Biomedecinepharmacotherapie. 154
Alzheimer's disease (AD) is a common neurodegenerative disease that often occurs in the elderly population. At present, most drugs for AD on the market are single-target drugs, which have achieved certain success in the treatment of AD. However, the
Publikováno v:
Bioorganic Chemistry. 114:105149
For the Alzheimer's disease (AD) with complex pathogenesis, single target drugs represent one of the most effective therapeutic strategies in clinical. However, the traditional concept of "a disease, a target" is difficult to find very effective drug